CompletedPhase 3NCT05445167
A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain
Studying Muscular tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Principal Investigator
- Yoshitaka ShimizuKissei Pharmaceutical Co., Ltd.
- Intervention
- KLH-2109(drug)
- Enrollment
- 89 target
- Eligibility
- 20 years · FEMALE
- Timeline
- 2022 – 2024
Study locations (1)
- Clinical Research Site, Multiple Locations, Japan
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05445167 on ClinicalTrials.govOther trials for Muscular tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07352761Bilateral Uterine Artery Occlusion During Laparoscopic MyomectomyAlexandria University
- RECRUITINGNANCT05683041Prevention of Intra-uterine Adhesions Following Laparoscopic and Laparotomic MyomectomyUniversity Hospital, Ghent
- ACTIVE NOT RECRUITINGNCT05607602Are Uterine Fibroids Pro-thrombotic?King's College Hospital NHS Trust